%0 Figure %A M., Merlini %A T., Kirabali %A L., Kulic %A R.M., Nitsch %A M.T., Ferretti %D 2018 %T Supplementary Material for: Extravascular CD3+ T Cells in Brains of Alzheimer Disease Patients Correlate with Tau but Not with Amyloid Pathology: An Immunohistochemical Study %U https://karger.figshare.com/articles/figure/Supplementary_Material_for_Extravascular_CD3_T_Cells_in_Brains_of_Alzheimer_Disease_Patients_Correlate_with_Tau_but_Not_with_Amyloid_Pathology_An_Immunohistochemical_Study/5857722 %R 10.6084/m9.figshare.5857722.v1 %2 https://ndownloader.figshare.com/files/10397520 %K Alzheimer disease %K T cells %K CD3 %K Amyloid %K Tau %K AT8 %K 6E10 %K Hippocampus %K Mid frontal gyrus %X

Background: Strong genetic and epidemiological evidence points to a crucial role of the immune system in the development of Alzheimer disease (AD). CD3+ T lymphocytes have been described in brains of postmortem AD patients and in transgenic models of AD-like cerebral amyloidosis and tau pathology. However, the occurrence of T cells in AD brains is still controversial; furthermore, the relationship between T cells and hallmarks of AD pathology (amyloid plaques and neurofibrillary tangles) remains to be established. Objectives: We have studied the occurrence of T cells in postmortem hippocampi and mid frontal gyrus (MFG) samples of AD patients (Braak stage V-VI) and nondemented control subjects and correlated it with amyloid and tau pathology burden. Methods: Confocal microscopy and bright-field immunohistochemistry were used to identify brain-associated T cells. Extravascular CD3+ T cells were quantified and compared to nondemented controls. In addition, numbers of extravascular CD3+ T cells were correlated with amyloid (6E10 staining) and tau pathology (AT8 staining) in the same sections. Results: Several CD3+, extravascular T cells were observed in the brains of AD patients, mostly of the CD8+ subtype. AD hippocampi harbored significantly increased numbers of extravascular CD3+ T cells compared to nondemented controls. CD3+ T cells significantly correlated with tau pathology but not with amyloid plaques in AD samples. Conclusions: Our data support the notion of T-cell occurrence in AD brains and suggest that, in advanced stages of AD, T-cell extravasation is driven by tau-related neurodegenerative changes rather than by cerebral amyloidosis. T cells could be crucial for driving the amyloid-independent phase of the AD pathology.

%I Karger Publishers